State Street Corp Voyager Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 892,743 shares of VYGR stock, worth $5.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

892,743

Previous 1,789,189 50.1%

Holding current value

$5.16 Million

Previous $14.2 Million 63.1%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.77 - $9.27 $5.17 Million - $8.31 Million	-896,446 Reduced 50.1%	892,743 $5.22 Million
Q2 2024 Aug 14, 2024	BUY	$7.42 - $10.54 $296,955 - $421,821	40,021 Added 2.29%	1,789,189 $14.2 Million
Q1 2024 May 15, 2024	BUY	$7.15 - $10.84 $8.07 Million - $12.2 Million	1,129,356 Added 182.21%	1,749,168 $16.3 Million
Q4 2023 Feb 14, 2024	BUY	$6.28 - $8.81 $236,021 - $331,106	37,583 Added 6.46%	619,812 $5.23 Million
Q3 2023 Nov 14, 2023	BUY	$7.55 - $11.25 $282,105 - $420,356	37,365 Added 6.86%	582,229 $4.51 Million
Q2 2023 Aug 14, 2023	BUY	$6.94 - $13.99 $3.13 Million - $6.31 Million	450,767 Added 479.05%	544,864 $6.24 Million
Q1 2023 May 15, 2023	BUY	$6.0 - $10.78 $31,800 - $57,134	5,300 Added 5.97%	94,097 $725,000
Q2 2022 Aug 15, 2022	SELL	$4.82 - $10.09 $22,172 - $46,414	-4,600 Reduced 4.93%	88,797 $525,000
Q1 2022 May 16, 2022	BUY	$2.75 - $9.44 $23,603 - $81,023	8,583 Added 10.12%	93,397 $712,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $5.44 $1.6 Million - $2.21 Million	-405,656 Reduced 82.71%	84,814 $350,000
Q1 2021 May 17, 2021	SELL	$4.61 - $9.04 $296,930 - $582,266	-64,410 Reduced 11.61%	490,470 $2.31 Million
Q4 2020 Feb 16, 2021	SELL	$7.15 - $12.28 $83,504 - $143,418	-11,679 Reduced 2.06%	554,880 $3.97 Million
Q3 2020 Nov 10, 2020	SELL	$10.01 - $13.75 $7.16 Million - $9.84 Million	-715,307 Reduced 55.8%	566,559 $6.05 Million
Q2 2020 Aug 14, 2020	SELL	$8.05 - $14.21 $706,661 - $1.25 Million	-87,784 Reduced 6.41%	1,281,866 $16.2 Million
Q1 2020 May 11, 2020	BUY	$6.8 - $14.66 $9.31 Million - $20.1 Million	1,369,650 New	1,369,650 $12.5 Million

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Voyager Therapeutics, Inc. Transaction History